Edward Currie

Ed leads tranScrip’s Medical Affairs Team. He is Deputy Head of the Oncology Team and works in other therapeutic areas, especially Infectious Diseases, and across the product lifecycle, with focus on Clinical Development and Medical Affairs.

A medical doctor by training, Ed has over 35 years of industry experience in the UK, Germany and Switzerland. He qualified in medicine in the UK and worked for 7 years in London teaching hospitals to Senior Registrar level, with specialist training in infection. He entered the pharmaceutical industry with Eli Lilly as International Clinical Research Physician, leading international antibiotic and antifungal clinical development programmes.

He then moved to Basel (where he remains based), to join F. Hoffmann-La Roche as Medical Director of their global Oncology/Virology business unit. Subsequent roles during 10 years at Roche were in oncology as Global Business Leader for MabThera (rituximab), in ophthalmology as Global Business Leader, and in companion diagnostics/personalised medicine as Founder/Head of Disease Management and Program Manager for Integrated Health Care Solutions.

Ed subsequently had leadership positions in venture-backed biotech/medtech companies, as COO of Swiss wound and bone healing company Kuros Biosurgery, and as Head of Corporate Development at German sepsis diagnostics company SIRS-Lab. He also held pharmaceutical consulting and business development roles at IBM and Infosys/Lodestone, and has been an advisor to several start-up companies and organisations